A study on chromoblastomycosis in a tertiary care hospital of eastern Odisha

Sarangi, Gitanjali; Dash, Muktikesh; Paty, Bimoch Projna; Mohapatra, Dharitri; Majhi, Subasini; Chayani, Nirupama

doi:10.4103/jms.jms_78_16

Cited by 4 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For localized and small lesion, cryotherapy, thermotherapy, laser vaporization, photodynamic therapy using 5-aminolevulinic acid, and surgical removal are other means of treatment (Ramraje et al 2013). • Differential diagnosis: Tuberculosis verrucosa cutis, mycetoma, sporotrichosis, squamous cell carcinoma, and dermal leishmaniasis (Sarangi et al 2017).…”

Section: Chromoblastomycosismentioning

confidence: 99%

Tropical Diseases of the Skin

Tiwary¹,

Kumar²,

S³

et al. 2020

Atlas of Dermatology, Dermatopathology and Venereology

View full text Add to dashboard Cite

Infectious dermatoses are the major burden of skin diseases prevalent in tropics. Some fungal, protozoal, and helminthic infestations are exclusively seen in tropical regions. Endemic pemphigus and few nutritional deficiencies account for majority of noninfectious tropical dermatoses. Basically, the climatic conditions and inhabiting human's culture and behavior are the chief attributable factors in acquiring and perpetuation of these diseases. Besides, migration and/or tourism further augment the risk of dissemination of tropical skin diseases to other regions of the world.

show abstract

Section: Chromoblastomycosismentioning

confidence: 99%

Tropical Diseases of the Skin

Tiwary¹,

Kumar²,

S³

et al. 2020

Atlas of Dermatology, Dermatopathology and Venereology

View full text Add to dashboard Cite

show abstract

“…The disease is transmitted by the fecal-oral route and often through contaminated drinking water. [6][7][8] Several outbreaks of this virus have been reported through contaminated food consumption and polluted water. 9,10 Another way to contract this virus is through sexual intercourse or close contact with an already infected person.…”

Section: Introductionmentioning

confidence: 99%

The Seroprevalence of Hepatitis A in Patients with Positive Human Immunodeficiency Virus

Omidifar,

Bagheri Lankarani,

Aghazadeh Ghadim

et al. 2023

Middle East J Dig Dis

View full text Add to dashboard Cite

Background: Hepatitis A virus (HAV) can have severe manifestations in adult patients with other liver diseases, particularly in those infected with human immunodeficiency virus (HIV). This study aimed to measure immunity against HAV in HIV-positive individuals to determine the necessity of vaccination against HAV in this population. Methods: This cross-sectional study investigated 171 HIV-positive patients aged 18 years or older who were tested for serum IgG anti-viral hepatitis A antibody. The prevalence and its determinants were analyzed based on patient data. Results: The average age of the patients was 44.2 years old. The prevalence of HAV antibody positivity was 97.7%. The prevalence was higher in patients older than 30 years. There was a close association between hepatitis C virus (HCV) infection (P=0.002). There were no significant correlations between antibody levels and sex, marital status, employment status, education level, economic status, smoking status, drug use status, and physical activity level. The mean and median CD4+counts in patients with positive (reactive) antibody (Ab) levels were 458 and 404±294, respectively, while the mean and median CD4+counts in patients with non-reactive antibody levels were 806 and 737±137, respectively, in those who tested negative for anti-HAV Ab (P=0.05). Conclusion: The prevalence of anti-hepatitis A IgG antibodies in people with HIV was very high in Shiraz. There is an increasing trend in the number of older patients and those with HCV infections. The negative association with CD4 was borderline in this study, which needs to be confirmed in larger groups

show abstract